Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia

NCT01810783 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT01810783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01810783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2013
Completion date
December 31, 2015
Enrollment
210 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia